In addition to innovation, internationalization of traditional Chinese medicine also faces many problems!

Market analysis of China Pharmaceutical network 】Recently, the State Administration of traditional Chinese medicine and the Ministry of science and Technology issued the guidance on strengthening the scientific and technological innovation of health services of traditional Chinese medicine By 2030, it is proposed to establish a scientific and technological innovation system of health services of traditional Chinese medicine with the whole life cycle health service chain of prevention, health care, and rehabilitation as the core, improve the collaborative innovation mechanism of "production, learning, research and medical treatment", and create scientific and technological innovation of health services of traditional Chinese medicine New capabilities and innovation driven capabilities have been significantly improved Industry insiders said that the modernization and internationalization of traditional Chinese medicine is the only way for traditional Chinese medicine to go out and benefit the world The implementation of this policy is conducive to improving the innovation ability of traditional Chinese medicine, but at present, the internationalization of traditional Chinese medicine still faces many problems There is no independent intellectual property right "Without their own products, Chinese enterprises will not be able to form advantages and core competitiveness," said the chairman of a pharmaceutical company If we want to get rid of the cruel competition of Western medicine market and the shackles of Western intellectual property, we must do modern Chinese medicine with independent intellectual property In the future, it can also be exported and become a "commando" to enter the international market " Therefore, only by further improving the intellectual property protection system and giving full play to the advantages of the company's independent intellectual property, can Chinese medicine enterprises enhance the company's core competitiveness Weak R & D power for enterprises, the development of its aftereffect is continuous innovation, especially in the aspect of R & D, but there are generally problems such as weak R & D power and shortage of innovative talents in Chinese medicine enterprises At present, in view of the research and development problem, the domestic pharmaceutical enterprises have also carried out new exploration and obtained certain achievements For example, some pharmaceutical enterprises are committed to the modernization and international research and development of traditional Chinese medicine, and have established extensive cooperation with many domestic and foreign research institutions, striving to open up a new path for traditional Chinese medicine, and constantly accelerating the pace of going global Brand influence is small Different from western medicine, traditional Chinese medicine products are restricted by many aspects Brand influence is generally small, so it is difficult to open the door of international market To this end, some insiders put forward that domestic national brands should develop and survive in the context of globalization, and HKEx can provide more international help for enterprises For example, Shenwei pharmaceutical is a modern Chinese medicine enterprise with the largest market value on the main board of the Hong Kong stock exchange As a national brand, it may also bring enlightenment to other enterprises Chinese medicine equipment needs to be upgraded Industry insiders said that the key process equipment of traditional Chinese medicine manufacturing mainly has the following status: basic hardware and facilities have not been fundamentally improved; advanced technology is not enough, online inspection technology is not effectively combined with process and equipment, process control is passive and level is not high; laws and regulations are not sensitive to process changes caused by equipment update and upgrading In view of the above defects, Chinese medicine equipment manufacturers should pay attention to improving the energy-saving, consumption reducing and water-saving control standards of Chinese medicine production; using automation and online detection technology to improve the quality control standards; according to the characteristics of Chinese medicine preparation, research and development of new intelligent equipment In addition, the development of green technology, such as low-temperature energy-saving drying technology, low-temperature sterilization technology Restricted by cultural differences, difficulties in standardization and many other factors, the road of internationalization is bumpy It is still very difficult for Chinese traditional medicine enterprises to go abroad So far, no therapeutic drugs of Chinese traditional medicine have been approved by the US FDA According to the industry, traditional Chinese medicine enterprises should firmly choose to "go out", actively promote the internationalization process of enterprises and traditional Chinese medicine industry through production, learning and research, and gradually form a unique internationalization mode.